These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 23181903)

  • 1. Toward Catalytic, Enantioselective Chlorolactonization of 1,2-Disubstituted Styrenyl Carboxylic Acids.
    Denmark SE; Ryabchuk P; Burk MT; Gilbert BB
    J Org Chem; 2016 Nov; 81(21):10411-10423. PubMed ID: 27555101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly enantio- and diastereoselective construction of spirocyclic oxindoles
    You P; Liu M; Zhang K; Yang F; Tan Z; Chen F
    Org Biomol Chem; 2024 Jun; 22(22):4466-4471. PubMed ID: 38771218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohols as Substrates and Solvents for the Construction of 3-Alkoxylated-2-Oxindoles by Direct Alkoxylation of 3-Halooxindoles.
    Lin B; Chen ZY; Liu HH; Wei QD; Feng TT; Zhou Y; Wang C; Liu XL; Yuan WC
    Molecules; 2017 May; 22(5):. PubMed ID: 28505098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Stereoconvergent Catalysis from 2005 to 2015: Transition-Metal-Mediated Stereoablative Reactions, Dynamic Kinetic Resolutions, and Dynamic Kinetic Asymmetric Transformations.
    Bhat V; Welin ER; Guo X; Stoltz BM
    Chem Rev; 2017 Mar; 117(5):4528-4561. PubMed ID: 28164696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioconvergent catalysis.
    Mohr JT; Moore JT; Stoltz BM
    Beilstein J Org Chem; 2016; 12():2038-2045. PubMed ID: 27829909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in catalytic, enantioselective alpha aminations and alpha oxygenations of carbonyl compounds.
    Janey JM
    Angew Chem Int Ed Engl; 2005 Jul; 44(28):4292-300. PubMed ID: 15945110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Keto acids in asymmetric metal catalysis and organocatalysis.
    Qin W; Subhani M; Jiang C; Lu H
    Org Biomol Chem; 2021 Dec; 19(46):10030-10046. PubMed ID: 34747960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective construction of 3-hydroxy oxindoles via decarboxylative addition of β-ketoacids to isatins.
    Zhong F; Yao W; Dou X; Lu Y
    Org Lett; 2012 Aug; 14(15):4018-21. PubMed ID: 22830448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organocatalytic enantioselective stereoablative hydroxylation of 3-halooxindoles: an effective method for the construction of enantioenriched 3-substituted 3-hydroxy-2-oxindoles.
    Liao YH; Wu ZJ; Han WY; Zhang XM; Yuan WC
    Chemistry; 2012 Jul; 18(29):8916-20. PubMed ID: 22715067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic enantioselective construction of quaternary stereocenters: assembly of key building blocks for the synthesis of biologically active molecules.
    Liu Y; Han SJ; Liu WB; Stoltz BM
    Acc Chem Res; 2015 Mar; 48(3):740-51. PubMed ID: 25715056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective synthesis of 3-hydroxy oxindoles by ytterbium-catalysed decarboxylative addition of β-ketoacids to isatins.
    Duan Z; Han J; Qian P; Zhang Z; Wang Y; Pan Y
    Org Biomol Chem; 2013 Oct; 11(38):6456-9. PubMed ID: 23979548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic catalytic enantioselective decarboxylative aldol reaction of β-ketoacids with trifluoromethyl ketones.
    Zheng Y; Xiong HY; Nie J; Hua MQ; Ma JA
    Chem Commun (Camb); 2012 May; 48(36):4308-10. PubMed ID: 22472878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organocatalyzed enantioselective decarboxylative stereoablation reaction for the construction of 3,3'-disubstituted oxindoles using β-ketoacids and 3-halooxindoles.
    Zuo J; Liao YH; Zhang XM; Yuan WC
    J Org Chem; 2012 Dec; 77(24):11325-32. PubMed ID: 23181903
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.